HOME >> MEDICINE >> NEWS
'Reduced exposure' tobacco products lessen carcinogen exposure, but medicinal nicotine better

Smokers and other tobacco users who switch to "reduced exposure" tobacco products lessen their exposure to tobacco-associated carcinogens, and those who switch to medicinal nicotine get an even greater reduction, according to a new study that appears in the June 2 issue of the Journal of the National Cancer Institute.

Tobacco users who cannot or will not quit but would like to limit their exposure to carcinogens may instead switch to tobacco products advertised as having less of these harmful chemicals. Although some tobacco companies have developed methods to reduce the formation of nitrosamines--the most abundant and potent tobacco carcinogens, which are created during the curing, fermentation, and aging of tobacco leaves--it is not known if, compared to medicinal nicotine, these products are safer or how much they reduce carcinogen exposure in people.

To evaluate the effects of switching to these products, Dorothy K. Hatsukami, Ph.D., of the University of Minnesota Transdisciplinary Tobacco Use Research Center in Minneapolis, and colleagues measured carcinogen uptake in 54 users of smokeless tobacco and 51 cigarette smokers who switched to either a "reduced exposure" tobacco product (Swedish snus for the smokeless tobacco users and OMNI cigarettes for the smokers) or medicinal nicotine (nicotine patch). The researchers measured levels of tobacco-specific nitrosamines in the urine of all participants weekly for 2 weeks before and 4 weeks after the switch. Smokers were also assessed for levels of a biomarker for polycyclic aromatic hydrocarbon uptake.

Each of the four groups of subjects had reduced levels of nitrosamines during the 4 weeks after the switch, although subjects in the medicinal nicotine groups had greater reductions. In addition, among the cigarette smokers, only those who switched to medicinal nicotine experienced a reduction in levels of the biomarker for polycyclic aromatic hydrocarbon uptake. The researchers also note that
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
1-Jun-2004


Page: 1 2

Related medicine news :

1. Short-term effects of spit tobacco suggest long-term health risks
2. Teen athletes continue tobacco use, despite severe consequences
3. Study examines racial differences among children to environmental tobacco smoke exposure
4. How links with tobacco industry may have influenced the publication of research on second-hand smoke
5. NIH awards USC $8.7 million to study tobacco use in China
6. Alcohol: Global burden on health similar to tobacco and high blood pressure
7. Marijuana associated with same respiratory symptoms as tobacco
8. Environmental tobacco smoke linked to reading, math, logic and reasoning declines in children
9. Leading tobacco manufacturer conceals links to tobacco research facility
10. European nations urged to ratify international treaty on tobacco control
11. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds

Post Your Comments:
(Date:10/30/2014)... By Dennis Thompson ... -- Drinking lots of milk could be bad for your ... that the calcium in milk can help strengthen bones and ... health officials to recommend milk as part of a healthy ... amounts of milk did not protect men or women from ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Eating a low-carb, high-fat ... treat, according to new research. A review ... Atkins diet, that focuses on foods like bacon, eggs, ... reduce seizures in adults whose condition doesn,t improve with ... percent of people with epilepsy whose seizures are not ...
(Date:10/30/2014)... new vaccine that could help prevent some cases of ... Food and Drug Administration on Wednesday. Trumenba is ... and 25 from invasive meningococcal disease caused by ... can infect the bloodstream (sepsis) and the lining that ... leading cause of bacterial meningitis, and infection can occur ...
(Date:10/30/2014)... standard of care for children facing acute myeloid leukemia ... in the latest edition of the New England ... John Wagner, Jr., M.D., director of the Pediatric Blood ... and a researcher in the Masonic Cancer Center, University ... and myelodysplastic syndrome who received transplants of either one ...
(Date:10/29/2014)... 2014 – Many of the women at first acted surprised. ... to researchers why they had not used the study products ... prevention trial that, as a likely consequence, did not find ... effective. , The women were among 127 former VOICE ... D, agreed to take part in in-depth interviews and/or focus ...
Breaking Medicine News(10 mins):Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 3Health News:Women who took part in VOICE speak up about why they didn't use HIV prevention products 2Health News:Women who took part in VOICE speak up about why they didn't use HIV prevention products 3
(Date:10/30/2014)... -- Zimmer Holdings, Inc. (NYSE: ZMH and ... and organizational structure of the combined company following the ... the combined organization will leverage the strength of both ... the new brand to be rolled out across the ... future leadership team is committed to establishing Zimmer Biomet ...
(Date:10/30/2014)... Oct. 30, 2014   ViaDerma, Inc. ... bringing new products to market, has recently released ... TetraStem is a topical liquid tetracycline-based antibiotic that ... can convert oral medication active ingredients into topical ... first aid antibiotic to help prevent skin infection ...
(Date:10/30/2014)... SAN FRANCISCO , Oct. 30, 2014  Nektar ... financial results for the third quarter ended September 30, ... of U.S.-based financial markets. Howard Robin , president ... to review the results beginning at 5:00 p.m. Eastern ... The press release and a live audio-only Webcast of ...
Breaking Medicine Technology:Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2
Cached News: